144 related articles for article (PubMed ID: 31989672)
21. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.
Carrera C; Gual A; Díaz A; Puig-Butillé JA; Noguès S; Vilalta A; Conill C; Rull R; Vilana R; Arguis P; Vidal-Sicart S; Alós L; Palou J; Castel T; Malvehy J; Puig S
Melanoma Res; 2017 Aug; 27(4):315-320. PubMed ID: 28296711
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
[TBL] [Abstract][Full Text] [Related]
24. Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.
Lino-Silva LS; Domínguez-Rodríguez JA; Aguilar-Romero JM; Martínez-Said H; Salcedo-Hernández RA; García-Pérez L; Herrera-Gómez Á; Cuellar-Hubbe M
Ann Surg Oncol; 2016 Dec; 23(13):4189-4194. PubMed ID: 27401447
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological characteristics and prognosis in significantly thick acral lentiginous melanoma in Taiwan.
Lee TL; Lin MH; Liao YH; Liau JY; Sheen YS
J Formos Med Assoc; 2022 Nov; 121(11):2338-2344. PubMed ID: 34961669
[TBL] [Abstract][Full Text] [Related]
26. Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.
Tas F; Erturk K
Pathobiology; 2018; 85(4):227-231. PubMed ID: 29860247
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
29. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
31. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients.
Teramoto Y; Keim U; Gesierich A; Schuler G; Fiedler E; Tüting T; Ulrich C; Wollina U; Hassel JC; Gutzmer R; Goerdt S; Zouboulis C; Leiter U; Eigentler TK; Garbe C
Br J Dermatol; 2018 Feb; 178(2):443-451. PubMed ID: 28707317
[TBL] [Abstract][Full Text] [Related]
32. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Factors and Clinical Outcomes of Clinical Node-Negative Cutaneous Malignant Melanoma Patients: An Asian Single Institute Study.
Chen YF; Ma H; Perng CK; Feng CJ
Ann Plast Surg; 2020 Jan; 84(1S Suppl 1):S48-S53. PubMed ID: 31833887
[TBL] [Abstract][Full Text] [Related]
34. Acral lentiginous melanoma. A histological type without prognostic significance.
Cascinelli N; Zurrida S; Galimberti V; Bartoli C; Bufalino R; Del Prato I; Mascheroni L; Testori A; Clemente C
J Dermatol Surg Oncol; 1994 Dec; 20(12):817-22. PubMed ID: 7798414
[TBL] [Abstract][Full Text] [Related]
35. Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study.
Mandalà M; Rutkowski P; Galli F; Patuzzo R; De Giorgi V; Rulli E; Gianatti A; Valeri B; Merelli B; Szumera-Ciećkiewicz A; Massi D; Maurichi A; Teterycz P; Santinami M
ESMO Open; 2022 Jun; 7(3):100469. PubMed ID: 35421840
[TBL] [Abstract][Full Text] [Related]
36. "Gloves-and-socks" melanoma: does histology make a difference?
Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
[TBL] [Abstract][Full Text] [Related]
37. Effect of changes in Breslow thickness between the initial punch biopsy results and final pathology reports in acral lentiginous melanoma patients.
Kim TH; Kim JC; Kwon JE; Kim YC; Choi JW
Sci Rep; 2021 Oct; 11(1):19885. PubMed ID: 34615974
[TBL] [Abstract][Full Text] [Related]
38. Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015.
Bian SX; Hwang L; Hwang J; Ragab O; In GK; Peng D; Lin E
Pigment Cell Melanoma Res; 2021 Nov; 34(6):1049-1061. PubMed ID: 34273249
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
40. Predictors of sentinel lymph node status of cutaneous melanoma in Serbian patients.
Jokic S; Markovic I; Bukumiric Z; Jokic V; Rakovic M; Tripkovic J; Stojiljkovic D; Spurnic I; Jevric M; Matic M; Dobrosavljevic D
J BUON; 2018; 23(2):468-474. PubMed ID: 29745094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
